4fn2
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[Image:4fn2.jpg|left|200px]] | ||
| - | |||
{{STRUCTURE_4fn2| PDB=4fn2 | SCENE= }} | {{STRUCTURE_4fn2| PDB=4fn2 | SCENE= }} | ||
| - | |||
===Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with surface mutation D44G from Burkholderia pseudomallei complexed with CJ37=== | ===Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with surface mutation D44G from Burkholderia pseudomallei complexed with CJ37=== | ||
| + | {{ABSTRACT_PUBMED_24366729}} | ||
| + | ==Function== | ||
| + | [[http://www.uniprot.org/uniprot/SMT3_YEAST SMT3_YEAST]] Not known; suppressor of MIF2 mutations. | ||
==About this Structure== | ==About this Structure== | ||
| - | [[4fn2]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | [[4fn2]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Burp1 Burp1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4FN2 OCA]. |
| - | [[Category: | + | |
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:024366729</ref><references group="xtra"/><references/> | ||
| + | [[Category: Burp1]] | ||
[[Category: Peptidylprolyl isomerase]] | [[Category: Peptidylprolyl isomerase]] | ||
[[Category: SSGCID, Seattle Structural Genomics Center for Infectious Disease.]] | [[Category: SSGCID, Seattle Structural Genomics Center for Infectious Disease.]] | ||
Revision as of 13:43, 12 March 2014
Contents |
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with surface mutation D44G from Burkholderia pseudomallei complexed with CJ37
Template:ABSTRACT PUBMED 24366729
Function
[SMT3_YEAST] Not known; suppressor of MIF2 mutations.
About this Structure
4fn2 is a 2 chain structure with sequence from Burp1. Full crystallographic information is available from OCA.
Reference
- Begley DW, Fox D 3rd, Jenner D, Juli C, Pierce PG, Abendroth J, Muruthi M, Safford K, Anderson V, Atkins K, Barnes SR, Moen SO, Raymond AC, Stacy R, Myler PJ, Staker BL, Harmer NJ, Norville IH, Holzgrabe U, Sarkar-Tyson M, Edwards TE, Lorimer DD. A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins. Antimicrob Agents Chemother. 2014 Mar;58(3):1458-67. doi: 10.1128/AAC.01875-13., Epub 2013 Dec 23. PMID:24366729 doi:http://dx.doi.org/10.1128/AAC.01875-13
